Metastatic Tumor clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
NKT3447 for Adults with Advanced/Metastatic Solid Tumors
Sorry, in progress, not accepting new patients
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, and pharmacokinetics (PK) to determine the maximum tolerated dose (MTD) and/or preliminary recommended dose for expansion (RDE) of NKT3447 in adults with…
San Francisco, California and other locations
Last updated: